To investigate the effect of ZNF503-AS2 on glioma function, we divided the glioma samples into high and low-expression groups according to the median value of ZNF503-AS2 expression and identified the DEGs between the two groups (|log2 (fold change)| > 2 and P < 0.05). The gene discussed is ZNF503; the disease is central nervous system cancer.